Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001056520-12-000153
Filing Date
2012-04-16
Accepted
2012-04-16 16:23:10
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 cellcyte201110kfinalclean.htm 10-K 568723
2 exhibit31.htm EX-31 12234
3 exhibit32.htm EX-32 4970
  Complete submission text file 0001056520-12-000153.txt   2080144

Data Files

Seq Description Document Type Size
4 ccyg-20111231.xml EX-101.INS 220787
5 ccyg-20111231.xsd EX-101.SCH 7486
6 ccyg-20111231_cal.xml EX-101.CAL 4834
7 ccyg-20111231_def.xml EX-101.DEF 9957
8 ccyg-20111231_lab.xml EX-101.LAB 104806
9 ccyg-20111231_pre.xml EX-101.PRE 81345
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52238 | Film No.: 12761277
SIC: 2834 Pharmaceutical Preparations